A review of 76 patients with myelodysplastic syndromes treated with danazol

Agustín Avilés, Christian Chabannon, Lysiane Molina, Brigitte Pggouric-Bandelier, Mirielle Bost, Jacqueline Lgger, Daniel J. Holland
In: Cancer · 1995 · vol. 75(1) , pp. 133–134 · doi:10.1002/1097-0142(19950101)75:1<133::aid-cncr2820750124>3.0.co;2-i · PMID:7804968 · W4253159671
review OA: closed CC0 ⤵ 2 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This review examined 76 myelodysplastic syndrome patients treated with danazol, reporting on their clinical outcomes and treatment responses.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (4)

Cited by (2)

References (5)

Cited by (2)

Source provenance

openalex
last seen: 2026-05-10T10:45:29.646959+00:00
License: CC0 · commercial use OK